You are viewing an incomplete version of our website. Please click to reload the website as full version.

p65 antibody (Nuclear Factor-KB P65) (pSer529)

Details for Product anti-NFkBP65 Antibody No. ABIN105287, Supplier: Log in to see
Antigen
  • NFkB
  • NFKB3
  • p65
Alternatives
anti-Human p65 antibody for Western Blotting
Epitope
pSer529
102
74
67
53
49
47
44
42
40
37
33
26
22
16
15
14
14
13
13
11
10
9
9
9
8
6
5
5
5
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
1019
477
393
44
37
26
11
10
6
4
4
3
2
2
2
1
1
1
1
1
Host
Rabbit
946
79
13
7
2
Clonality
Polyclonal
Conjugate
This p65 antibody is un-conjugated
31
30
22
19
16
16
11
9
8
8
8
8
8
8
8
1
1
1
1
1
Application
Immunoprecipitation (IP), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
741
395
337
160
129
126
89
33
30
21
20
17
11
9
7
7
6
4
2
2
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen NFkB p65 (Rel A) peptide corresponding to a region near phospho Serine 529 of the human protein conjugated to Keyhole Limpet Hemocyanin (KLH).
Characteristics Concentration Definition: by Refractometry
Purification Antiserum
Alternative Name NFkB p65 (RelA) (NFkBP65 Antibody Abstract)
Background NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. Anti-NFkB antibody is ideal for Cell Biology, Nuclear Signaling, Neuroscience and Signal Transduction Research
Synonyms: NFKB, nfkb, NF-kB, NF-kappaB, NFkappaB
Gene ID 5970, 223468676
UniProt Q04206
Pathways NF-kappaB Signaling, RTK Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway
Application Notes Anti-phospho NFkB antibody reacts human pS529 p65 and shows minimal reactivity by western blot with non-phosphorylated p65 and minimal reactivity by ELISA against the non-phosphorylated form of the immunizing peptide.  Although not tested, this antibody is likely functional in immunohistochemistry and immunoprecipitation.
Restrictions For Research Use only
Format Liquid
Concentration 75 mg/mL
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Supplier Images
Western Blotting (WB) image for anti-p65 antibody (Nuclear Factor-KB P65) (pSer529) (ABIN105287) TNF Induces phosphorylation of p65 in KBM-5 cells.  Cytoplasmic and nuclear protein l...
Western Blotting (WB) image for anti-p65 antibody (Nuclear Factor-KB P65) (pSer529) (ABIN105287) anti-Nuclear Factor-KB P65 (NFkBP65) (pSer529) antibody (Image 2)
 image for anti-p65 antibody (Nuclear Factor-KB P65) (pSer529) (ABIN105287) anti-Nuclear Factor-KB P65 (NFkBP65) (pSer529) antibody (Image 3)
 image for anti-p65 antibody (Nuclear Factor-KB P65) (pSer529) (ABIN105287) anti-Nuclear Factor-KB P65 (NFkBP65) (pSer529) antibody (Image 4)
Product cited in: Gavert, Ben-Shmuel, Lemmon, Brabletz, Ben-Zeev: "Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells." in: Journal of cell science, Vol. 123, Issue Pt 12, pp. 2135-43, 2010

Amith, Jayanth, Franchuk, Finlay, Seyrantepe, Beyaert, Pshezhetsky, Szewczuk: "Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling." in: Cellular signalling, 2009

Shakibaei, John, Schulze-Tanzil, Lehmann, Mobasheri: "Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis." in: Biochemical pharmacology, Vol. 73, Issue 9, pp. 1434-45, 2007

Did you look for something else?